The independent source for health policy research, polling, and news.
441 - 460 of 112,272 Results
For 50 years, the Clean Air Scientific Advisory Committee that counsels the EPA's leadership on scientific evidence about pollutants has filled the obligatory physician's seat with pulmonologists or cardiologists. Now the role will be filled by an ophthalmologist and political commentator.
Wednesday morning's cyberattack targeted Stryker's Microsoft programs across the globe. The company said it thinks the attack has been contained. Plus, news outlets look at how artificial intelligence is being used in the health sector.
The county saw a 10% decrease in the rate of homeless deaths from all causes in 2024, driven by a sharp decrease in overdose deaths. Public health officials credit the wide availability of naloxone but worry that a decrease in funding over the past year may reverse the positive trends.
The gathering of the pared-down Vaccine and Related Biological Products Advisory Committee — whose members all have expertise in infectious diseases, immunology, or global health and genetics — is seen as a good sign, public health advocates say.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Opinion writers delve into these public health issues and others.
Under the new effort, the Justice Department would give Veterans Affairs officials authority to initiate guardianship proceedings in state courts for veterans who lack family and are “unable to make their own health care decisions,” including some veterans who are homeless or “at risk of homelessness."
Two new Gallup polls also found that roughly half of middle-income households reported delaying a major life event in order to afford health care costs. Meanwhile, food stamp recipients are suing the Agriculture Department over sugary drink bans.
Today's early morning highlights from the major news organizations.
As FiercePharma explains, the company is attempting to rebrand itself in the wake of a Justice Department investigation, a class-action lawsuit, and a failed attempt at treating Alzheimer’s. Plus: The FDA says Novo failed to report suspected incidents of GLP-1 side effects, as required by law.
Researchers looked at levels of p-tau217 among women with no signs of cognitive issues and found that those with higher levels were "much more likely" to develop dementia. Also: Psilocybin might be better at helping smokers quit than nicotine patches, researchers say.
Opinion writers discuss medical school, the FDA's Center for Biologics Evaluation and Research, and more.
The Washington Post, citing two people familiar with the matter who spoke on the condition of anonymity, reported that the Advisory Committee on Immunization Practices has dropped its questioning of covid shots' safety amid Republicans' fears that more changes to vaccine policy could hurt the party in the midterm elections.
The Trump administration has touted the synthetic vitamin B9 as a way to treat autism, but there is insufficient data to support the drug's use for it, an FDA official said. The new approval is for the treatment of cerebral folate deficiency.
The Joint Economic Committee found that last year, the average American senior’s Medicare premiums were about 10% higher, or more than $200 annually, because of the alleged overpayments. Also: a CBS News analysis of alleged fraud among hospices in Los Angeles.
The legislation includes $31 million to reinstate eligibility to thousands of people who lost coverage March 1 in the wake of a $120 million budget shortfall caused by federal funding cuts, WUSF reported. Separately, Missouri lawmakers have cleared the way for pregnant people to get a divorce.
Today's early morning highlights from the major news organizations.
The procedure will be allowed to protect the life of a woman. Abortion advocates plan to ask the courts to block the ban. “Regrettably, this act represents another well-intentioned but likely fragile legal effort with significant risk of ending in the courts," Republican Gov. Mark Gordon has said.
According to the Food and Drug Administration, biologic medicines make up about 5% of prescriptions, yet they account for 51% of drug spending. Other FDA news is on a probe into rare-disease drug denials, flavored e-cigarettes, and more.
© 2026 KFF